English 
Revealed: Actinium KOLs Engagement and Pioneering Strategies for Iomab-B and Actimab-A
As Actinium forges ahead with its transformative therapies, including Iomab-B and Actimab-A, its strategic approach extends beyond clinical trials and regulatory milestones. Actinium’s presentation of six abstracts at the Society for Nuclear Medicine and Molecular […]